Global In-vitro Toxicity Testing Market Growth (Status and Outlook) 2025-2031

December 2025 | 95 pages | ID: GB09C87EFE4DEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to this study, the global In-vitro Toxicity Testing market size will reach US$ million by 2031.

In-vitro and in-silico testing methods are being preferred over in-vivo testing methods in the pharmaceutical industry because of the growing need to detect diseases at the molecular level and identify biological functionalities with minimal adverse effects.

The development of advanced technologies, such as 3D cell culture technologies, cellular imaging technologies, and toxicogenomics has further supported the adoption of in-vitro testing methods. These technologies help in replicating in-vivo systems and thereby eliminate the need to experiment on human or animal models.

LPI (LP Information)' newest research report, the “In-vitro Toxicity Testing Industry Forecast” looks at past sales and reviews total world In-vitro Toxicity Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected In-vitro Toxicity Testing sales for 2025 through 2031. With In-vitro Toxicity Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world In-vitro Toxicity Testing industry.

This Insight Report provides a comprehensive analysis of the global In-vitro Toxicity Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on In-vitro Toxicity Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global In-vitro Toxicity Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for In-vitro Toxicity Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global In-vitro Toxicity Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of In-vitro Toxicity Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • Static Well Plate System
  • Multi-compartmental Perfused Systems
Segmentation by Application:
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutions
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • CELTHER POLSKA Sp z o.o.
  • Charles River Laboratories International Inc.
  • Eurofins GSC Lux Sarl
  • Evotec AG
  • General Electric Co.
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global In-vitro Toxicity Testing Market Size (2020-2031)
  2.1.2 In-vitro Toxicity Testing Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for In-vitro Toxicity Testing by Country/Region (2020, 2024 & 2031)
2.2 In-vitro Toxicity Testing Segment by Type
  2.2.1 Static Well Plate System
  2.2.2 Multi-compartmental Perfused Systems
2.3 In-vitro Toxicity Testing Market Size by Type
  2.3.1 In-vitro Toxicity Testing Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global In-vitro Toxicity Testing Market Size Market Share by Type (2020-2025)
2.4 In-vitro Toxicity Testing Segment by Application
  2.4.1 Pharmaceutical and Biotechnology Companies
  2.4.2 Academic and Research Institutions
  2.4.3 Others
2.5 In-vitro Toxicity Testing Market Size by Application
  2.5.1 In-vitro Toxicity Testing Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global In-vitro Toxicity Testing Market Size Market Share by Application (2020-2025)

3 IN-VITRO TOXICITY TESTING MARKET SIZE BY PLAYER

3.1 In-vitro Toxicity Testing Market Size Market Share by Player
  3.1.1 Global In-vitro Toxicity Testing Revenue by Player (2020-2025)
  3.1.2 Global In-vitro Toxicity Testing Revenue Market Share by Player (2020-2025)
3.2 Global In-vitro Toxicity Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 IN-VITRO TOXICITY TESTING BY REGION

4.1 In-vitro Toxicity Testing Market Size by Region (2020-2025)
4.2 Global In-vitro Toxicity Testing Annual Revenue by Country/Region (2020-2025)
4.3 Americas In-vitro Toxicity Testing Market Size Growth (2020-2025)
4.4 APAC In-vitro Toxicity Testing Market Size Growth (2020-2025)
4.5 Europe In-vitro Toxicity Testing Market Size Growth (2020-2025)
4.6 Middle East & Africa In-vitro Toxicity Testing Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas In-vitro Toxicity Testing Market Size by Country (2020-2025)
5.2 Americas In-vitro Toxicity Testing Market Size by Type (2020-2025)
5.3 Americas In-vitro Toxicity Testing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC In-vitro Toxicity Testing Market Size by Region (2020-2025)
6.2 APAC In-vitro Toxicity Testing Market Size by Type (2020-2025)
6.3 APAC In-vitro Toxicity Testing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe In-vitro Toxicity Testing Market Size by Country (2020-2025)
7.2 Europe In-vitro Toxicity Testing Market Size by Type (2020-2025)
7.3 Europe In-vitro Toxicity Testing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa In-vitro Toxicity Testing by Region (2020-2025)
8.2 Middle East & Africa In-vitro Toxicity Testing Market Size by Type (2020-2025)
8.3 Middle East & Africa In-vitro Toxicity Testing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL IN-VITRO TOXICITY TESTING MARKET FORECAST

10.1 Global In-vitro Toxicity Testing Forecast by Region (2026-2031)
  10.1.1 Global In-vitro Toxicity Testing Forecast by Region (2026-2031)
  10.1.2 Americas In-vitro Toxicity Testing Forecast
  10.1.3 APAC In-vitro Toxicity Testing Forecast
  10.1.4 Europe In-vitro Toxicity Testing Forecast
  10.1.5 Middle East & Africa In-vitro Toxicity Testing Forecast
10.2 Americas In-vitro Toxicity Testing Forecast by Country (2026-2031)
  10.2.1 United States Market In-vitro Toxicity Testing Forecast
  10.2.2 Canada Market In-vitro Toxicity Testing Forecast
  10.2.3 Mexico Market In-vitro Toxicity Testing Forecast
  10.2.4 Brazil Market In-vitro Toxicity Testing Forecast
10.3 APAC In-vitro Toxicity Testing Forecast by Region (2026-2031)
  10.3.1 China In-vitro Toxicity Testing Market Forecast
  10.3.2 Japan Market In-vitro Toxicity Testing Forecast
  10.3.3 Korea Market In-vitro Toxicity Testing Forecast
  10.3.4 Southeast Asia Market In-vitro Toxicity Testing Forecast
  10.3.5 India Market In-vitro Toxicity Testing Forecast
  10.3.6 Australia Market In-vitro Toxicity Testing Forecast
10.4 Europe In-vitro Toxicity Testing Forecast by Country (2026-2031)
  10.4.1 Germany Market In-vitro Toxicity Testing Forecast
  10.4.2 France Market In-vitro Toxicity Testing Forecast
  10.4.3 UK Market In-vitro Toxicity Testing Forecast
  10.4.4 Italy Market In-vitro Toxicity Testing Forecast
  10.4.5 Russia Market In-vitro Toxicity Testing Forecast
10.5 Middle East & Africa In-vitro Toxicity Testing Forecast by Region (2026-2031)
  10.5.1 Egypt Market In-vitro Toxicity Testing Forecast
  10.5.2 South Africa Market In-vitro Toxicity Testing Forecast
  10.5.3 Israel Market In-vitro Toxicity Testing Forecast
  10.5.4 Turkey Market In-vitro Toxicity Testing Forecast
10.6 Global In-vitro Toxicity Testing Forecast by Type (2026-2031)
10.7 Global In-vitro Toxicity Testing Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market In-vitro Toxicity Testing Forecast

11 KEY PLAYERS ANALYSIS

11.1 Abbott Laboratories
  11.1.1 Abbott Laboratories Company Information
  11.1.2 Abbott Laboratories In-vitro Toxicity Testing Product Offered
  11.1.3 Abbott Laboratories In-vitro Toxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Abbott Laboratories Main Business Overview
  11.1.5 Abbott Laboratories Latest Developments
11.2 Agilent Technologies Inc.
  11.2.1 Agilent Technologies Inc. Company Information
  11.2.2 Agilent Technologies Inc. In-vitro Toxicity Testing Product Offered
  11.2.3 Agilent Technologies Inc. In-vitro Toxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Agilent Technologies Inc. Main Business Overview
  11.2.5 Agilent Technologies Inc. Latest Developments
11.3 Bio-Rad Laboratories Inc.
  11.3.1 Bio-Rad Laboratories Inc. Company Information
  11.3.2 Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Product Offered
  11.3.3 Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Bio-Rad Laboratories Inc. Main Business Overview
  11.3.5 Bio-Rad Laboratories Inc. Latest Developments
11.4 CELTHER POLSKA Sp z o.o.
  11.4.1 CELTHER POLSKA Sp z o.o. Company Information
  11.4.2 CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Product Offered
  11.4.3 CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 CELTHER POLSKA Sp z o.o. Main Business Overview
  11.4.5 CELTHER POLSKA Sp z o.o. Latest Developments
11.5 Charles River Laboratories International Inc.
  11.5.1 Charles River Laboratories International Inc. Company Information
  11.5.2 Charles River Laboratories International Inc. In-vitro Toxicity Testing Product Offered
  11.5.3 Charles River Laboratories International Inc. In-vitro Toxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Charles River Laboratories International Inc. Main Business Overview
  11.5.5 Charles River Laboratories International Inc. Latest Developments
11.6 Eurofins GSC Lux Sarl
  11.6.1 Eurofins GSC Lux Sarl Company Information
  11.6.2 Eurofins GSC Lux Sarl In-vitro Toxicity Testing Product Offered
  11.6.3 Eurofins GSC Lux Sarl In-vitro Toxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Eurofins GSC Lux Sarl Main Business Overview
  11.6.5 Eurofins GSC Lux Sarl Latest Developments
11.7 Evotec AG
  11.7.1 Evotec AG Company Information
  11.7.2 Evotec AG In-vitro Toxicity Testing Product Offered
  11.7.3 Evotec AG In-vitro Toxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Evotec AG Main Business Overview
  11.7.5 Evotec AG Latest Developments
11.8 General Electric Co.
  11.8.1 General Electric Co. Company Information
  11.8.2 General Electric Co. In-vitro Toxicity Testing Product Offered
  11.8.3 General Electric Co. In-vitro Toxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 General Electric Co. Main Business Overview
  11.8.5 General Electric Co. Latest Developments
11.9 Merck KGaA
  11.9.1 Merck KGaA Company Information
  11.9.2 Merck KGaA In-vitro Toxicity Testing Product Offered
  11.9.3 Merck KGaA In-vitro Toxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Merck KGaA Main Business Overview
  11.9.5 Merck KGaA Latest Developments
11.10 Thermo Fisher Scientific Inc.
  11.10.1 Thermo Fisher Scientific Inc. Company Information
  11.10.2 Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Product Offered
  11.10.3 Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Thermo Fisher Scientific Inc. Main Business Overview
  11.10.5 Thermo Fisher Scientific Inc. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. In-vitro Toxicity Testing Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. In-vitro Toxicity Testing Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Static Well Plate System
Table 4. Major Players of Multi-compartmental Perfused Systems
Table 5. In-vitro Toxicity Testing Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global In-vitro Toxicity Testing Market Size by Type (2020-2025) & ($ millions)
Table 7. Global In-vitro Toxicity Testing Market Size Market Share by Type (2020-2025)
Table 8. In-vitro Toxicity Testing Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global In-vitro Toxicity Testing Market Size by Application (2020-2025) & ($ millions)
Table 10. Global In-vitro Toxicity Testing Market Size Market Share by Application (2020-2025)
Table 11. Global In-vitro Toxicity Testing Revenue by Player (2020-2025) & ($ millions)
Table 12. Global In-vitro Toxicity Testing Revenue Market Share by Player (2020-2025)
Table 13. In-vitro Toxicity Testing Key Players Head office and Products Offered
Table 14. In-vitro Toxicity Testing Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global In-vitro Toxicity Testing Market Size by Region (2020-2025) & ($ millions)
Table 18. Global In-vitro Toxicity Testing Market Size Market Share by Region (2020-2025)
Table 19. Global In-vitro Toxicity Testing Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global In-vitro Toxicity Testing Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas In-vitro Toxicity Testing Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas In-vitro Toxicity Testing Market Size Market Share by Country (2020-2025)
Table 23. Americas In-vitro Toxicity Testing Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas In-vitro Toxicity Testing Market Size Market Share by Type (2020-2025)
Table 25. Americas In-vitro Toxicity Testing Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas In-vitro Toxicity Testing Market Size Market Share by Application (2020-2025)
Table 27. APAC In-vitro Toxicity Testing Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC In-vitro Toxicity Testing Market Size Market Share by Region (2020-2025)
Table 29. APAC In-vitro Toxicity Testing Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC In-vitro Toxicity Testing Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe In-vitro Toxicity Testing Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe In-vitro Toxicity Testing Market Size Market Share by Country (2020-2025)
Table 33. Europe In-vitro Toxicity Testing Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe In-vitro Toxicity Testing Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa In-vitro Toxicity Testing Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa In-vitro Toxicity Testing Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa In-vitro Toxicity Testing Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of In-vitro Toxicity Testing
Table 39. Key Market Challenges & Risks of In-vitro Toxicity Testing
Table 40. Key Industry Trends of In-vitro Toxicity Testing
Table 41. Global In-vitro Toxicity Testing Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global In-vitro Toxicity Testing Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global In-vitro Toxicity Testing Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global In-vitro Toxicity Testing Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Abbott Laboratories Details, Company Type, In-vitro Toxicity Testing Area Served and Its Competitors
Table 46. Abbott Laboratories In-vitro Toxicity Testing Product Offered
Table 47. Abbott Laboratories In-vitro Toxicity Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Abbott Laboratories Main Business
Table 49. Abbott Laboratories Latest Developments
Table 50. Agilent Technologies Inc. Details, Company Type, In-vitro Toxicity Testing Area Served and Its Competitors
Table 51. Agilent Technologies Inc. In-vitro Toxicity Testing Product Offered
Table 52. Agilent Technologies Inc. In-vitro Toxicity Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Agilent Technologies Inc. Main Business
Table 54. Agilent Technologies Inc. Latest Developments
Table 55. Bio-Rad Laboratories Inc. Details, Company Type, In-vitro Toxicity Testing Area Served and Its Competitors
Table 56. Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Product Offered
Table 57. Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Bio-Rad Laboratories Inc. Main Business
Table 59. Bio-Rad Laboratories Inc. Latest Developments
Table 60. CELTHER POLSKA Sp z o.o. Details, Company Type, In-vitro Toxicity Testing Area Served and Its Competitors
Table 61. CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Product Offered
Table 62. CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. CELTHER POLSKA Sp z o.o. Main Business
Table 64. CELTHER POLSKA Sp z o.o. Latest Developments
Table 65. Charles River Laboratories International Inc. Details, Company Type, In-vitro Toxicity Testing Area Served and Its Competitors
Table 66. Charles River Laboratories International Inc. In-vitro Toxicity Testing Product Offered
Table 67. Charles River Laboratories International Inc. In-vitro Toxicity Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Charles River Laboratories International Inc. Main Business
Table 69. Charles River Laboratories International Inc. Latest Developments
Table 70. Eurofins GSC Lux Sarl Details, Company Type, In-vitro Toxicity Testing Area Served and Its Competitors
Table 71. Eurofins GSC Lux Sarl In-vitro Toxicity Testing Product Offered
Table 72. Eurofins GSC Lux Sarl In-vitro Toxicity Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Eurofins GSC Lux Sarl Main Business
Table 74. Eurofins GSC Lux Sarl Latest Developments
Table 75. Evotec AG Details, Company Type, In-vitro Toxicity Testing Area Served and Its Competitors
Table 76. Evotec AG In-vitro Toxicity Testing Product Offered
Table 77. Evotec AG In-vitro Toxicity Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Evotec AG Main Business
Table 79. Evotec AG Latest Developments
Table 80. General Electric Co. Details, Company Type, In-vitro Toxicity Testing Area Served and Its Competitors
Table 81. General Electric Co. In-vitro Toxicity Testing Product Offered
Table 82. General Electric Co. In-vitro Toxicity Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. General Electric Co. Main Business
Table 84. General Electric Co. Latest Developments
Table 85. Merck KGaA Details, Company Type, In-vitro Toxicity Testing Area Served and Its Competitors
Table 86. Merck KGaA In-vitro Toxicity Testing Product Offered
Table 87. Merck KGaA In-vitro Toxicity Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Merck KGaA Main Business
Table 89. Merck KGaA Latest Developments
Table 90. Thermo Fisher Scientific Inc. Details, Company Type, In-vitro Toxicity Testing Area Served and Its Competitors
Table 91. Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Product Offered
Table 92. Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Thermo Fisher Scientific Inc. Main Business
Table 94. Thermo Fisher Scientific Inc. Latest Developments

LIST OF FIGURES

Figure 1. In-vitro Toxicity Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global In-vitro Toxicity Testing Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. In-vitro Toxicity Testing Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. In-vitro Toxicity Testing Sales Market Share by Country/Region (2024)
Figure 8. In-vitro Toxicity Testing Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global In-vitro Toxicity Testing Market Size Market Share by Type in 2024
Figure 10. In-vitro Toxicity Testing in Pharmaceutical and Biotechnology Companies
Figure 11. Global In-vitro Toxicity Testing Market: Pharmaceutical and Biotechnology Companies (2020-2025) & ($ millions)
Figure 12. In-vitro Toxicity Testing in Academic and Research Institutions
Figure 13. Global In-vitro Toxicity Testing Market: Academic and Research Institutions (2020-2025) & ($ millions)
Figure 14. In-vitro Toxicity Testing in Others
Figure 15. Global In-vitro Toxicity Testing Market: Others (2020-2025) & ($ millions)
Figure 16. Global In-vitro Toxicity Testing Market Size Market Share by Application in 2024
Figure 17. Global In-vitro Toxicity Testing Revenue Market Share by Player in 2024
Figure 18. Global In-vitro Toxicity Testing Market Size Market Share by Region (2020-2025)
Figure 19. Americas In-vitro Toxicity Testing Market Size 2020-2025 ($ millions)
Figure 20. APAC In-vitro Toxicity Testing Market Size 2020-2025 ($ millions)
Figure 21. Europe In-vitro Toxicity Testing Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa In-vitro Toxicity Testing Market Size 2020-2025 ($ millions)
Figure 23. Americas In-vitro Toxicity Testing Value Market Share by Country in 2024
Figure 24. United States In-vitro Toxicity Testing Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada In-vitro Toxicity Testing Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico In-vitro Toxicity Testing Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil In-vitro Toxicity Testing Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC In-vitro Toxicity Testing Market Size Market Share by Region in 2024
Figure 29. APAC In-vitro Toxicity Testing Market Size Market Share by Type (2020-2025)
Figure 30. APAC In-vitro Toxicity Testing Market Size Market Share by Application (2020-2025)
Figure 31. China In-vitro Toxicity Testing Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan In-vitro Toxicity Testing Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea In-vitro Toxicity Testing Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia In-vitro Toxicity Testing Market Size Growth 2020-2025 ($ millions)
Figure 35. India In-vitro Toxicity Testing Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia In-vitro Toxicity Testing Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe In-vitro Toxicity Testing Market Size Market Share by Country in 2024
Figure 38. Europe In-vitro Toxicity Testing Market Size Market Share by Type (2020-2025)
Figure 39. Europe In-vitro Toxicity Testing Market Size Market Share by Application (2020-2025)
Figure 40. Germany In-vitro Toxicity Testing Market Size Growth 2020-2025 ($ millions)
Figure 41. France In-vitro Toxicity Testing Market Size Growth 2020-2025 ($ millions)
Figure 42. UK In-vitro Toxicity Testing Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy In-vitro Toxicity Testing Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia In-vitro Toxicity Testing Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa In-vitro Toxicity Testing Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa In-vitro Toxicity Testing Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa In-vitro Toxicity Testing Market Size Market Share by Application (2020-2025)
Figure 48. Egypt In-vitro Toxicity Testing Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa In-vitro Toxicity Testing Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel In-vitro Toxicity Testing Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey In-vitro Toxicity Testing Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries In-vitro Toxicity Testing Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas In-vitro Toxicity Testing Market Size 2026-2031 ($ millions)
Figure 54. APAC In-vitro Toxicity Testing Market Size 2026-2031 ($ millions)
Figure 55. Europe In-vitro Toxicity Testing Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa In-vitro Toxicity Testing Market Size 2026-2031 ($ millions)
Figure 57. United States In-vitro Toxicity Testing Market Size 2026-2031 ($ millions)
Figure 58. Canada In-vitro Toxicity Testing Market Size 2026-2031 ($ millions)
Figure 59. Mexico In-vitro Toxicity Testing Market Size 2026-2031 ($ millions)
Figure 60. Brazil In-vitro Toxicity Testing Market Size 2026-2031 ($ millions)
Figure 61. China In-vitro Toxicity Testing Market Size 2026-2031 ($ millions)
Figure 62. Japan In-vitro Toxicity Testing Market Size 2026-2031 ($ millions)
Figure 63. Korea In-vitro Toxicity Testing Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia In-vitro Toxicity Testing Market Size 2026-2031 ($ millions)
Figure 65. India In-vitro Toxicity Testing Market Size 2026-2031 ($ millions)
Figure 66. Australia In-vitro Toxicity Testing Market Size 2026-2031 ($ millions)
Figure 67. Germany In-vitro Toxicity Testing Market Size 2026-2031 ($ millions)
Figure 68. France In-vitro Toxicity Testing Market Size 2026-2031 ($ millions)
Figure 69. UK In-vitro Toxicity Testing Market Size 2026-2031 ($ millions)
Figure 70. Italy In-vitro Toxicity Testing Market Size 2026-2031 ($ millions)
Figure 71. Russia In-vitro Toxicity Testing Market Size 2026-2031 ($ millions)
Figure 72. Egypt In-vitro Toxicity Testing Market Size 2026-2031 ($ millions)
Figure 73. South Africa In-vitro Toxicity Testing Market Size 2026-2031 ($ millions)
Figure 74. Israel In-vitro Toxicity Testing Market Size 2026-2031 ($ millions)
Figure 75. Turkey In-vitro Toxicity Testing Market Size 2026-2031 ($ millions)
Figure 76. Global In-vitro Toxicity Testing Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global In-vitro Toxicity Testing Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries In-vitro Toxicity Testing Market Size 2026-2031 ($ millions)